Iodomethane

Iodomethane

SCHEMBL4054071

CI.COc1ccc2nc(C)sc2c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2C19 P33261 2/20 0.63
TDP1 Q9NUW8 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
PDK1 Q15118 1/20 0.61
MAPT P10636 3/20 0.59
TSHR P16473 1/20 0.59
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
APP P05067 2/20 0.54
HTT P42858 1/20 0.52
DYRK1A Q13627 1/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422166 0.96 CYP1A2 (0.67) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL9190961 0.92 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL2170339 0.86 CYP1A2 (0.55) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL19850971 0.84 TDP1 (0.64) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL13862753 0.83 NPC1 (0.56) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL25250383 0.82 TDP1 (0.55) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
Hydrochlorthiazide SCHEMBL9735331 0.82 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL31276816 0.82 NPC1 (0.55) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL95067 0.82 NPC1 (0.55) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1
SCHEMBL2172527 0.81 TDP1 (0.57) CYP1A2CYP3A4CYP2C19TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247579-A1 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED 2009-10-01 US disclosed
EP-2029584-A2 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE Cancer Research Technology Limited (GB) 2009-03-04 EP disclosed
WO-2007096618-A2 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247579-A1 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE RB1, RBBP5, RRM2B CYP1A2 2027/4885CYP3A4 2709/4885CYP2C19 4260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.